Evidence map›Paper›PMID 35230668›Full record

ArticleJournal of physiology and biochemistry2022

Cordycepin alleviates myocardial ischemia/reperfusion injury by enhancing autophagy via AMPK-mTOR pathway.

Han Xu, Jing Cheng, Fei He

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Cordycepin alleviates nicotine withdrawal-induced anxietyDrug and alcohol dependence reports · 2026
    Article
  3. Article
  4. Review
  5. Anti-Inflammatory Mechanisms and Translational Relevance ofJournal of inflammation research · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Han Xu *Department of Cardiology, second affiliated hospital of Anhui medical University, Hefei, Anhui, China.
Jing ChengSchool of Nursing, Anhui University of Traditional Chinese Medicine, No.103 of middle Meishan Road, Hefei, Anhui, China.
Fei HeDepartment of Cardiology, second affiliated hospital of Anhui medical University, Hefei, Anhui, China. coffeelove3344@163.com.
Anhui Medical University · CNAnhui University of Traditional Chinese Medicine · CNHuadong Hospital · CN

Funding

Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province gxyq2019013Key Natural Science Project of Anhui Colleges and Universities KJ2018A0284Natural Science Foundation of Anhui Province 1808085QH235Natural science foundation of china 81903833Science and Technology New Star Program of Second affiliated Hospital of Anhui Medical University 2018KA06
6 · The paper itself

Abstract

To estimate the cardioprotective mechanism of cordycepin on myocardial ischemia/reperfusion (I/R) injury. The left anterior descending artery of mice was ligated transiently to establish the myocardial I/R model. TTC/Evans Blue staining and TUNEL assay were performed to quantify the infarct size and apoptosis index. The cardiac function was evaluated by echocardiography. Neonatal rat ventricular cardiomyocytes (NRVCs) underwent hypoxia and reoxygenation (H/R). MTS and LDH were detected to measured cell viability and necrosis respectively. The results suggested that cordycepin could markedly decrease apoptosis, reduce infarct size, and improve cardiac function in mice subjected to I/R injury, alongside with enhanced autophagy. In NRVCs, cordycepin treatment obviously reduced ROS production. In addition, cordycepin partly promoted autophagy in the context of H/R injury by regulating AMPK/mTOR pathway. Our data demonstrated that cordycepin exerts cardio-protective effect and promotes cardiac functional recovery following myocardial I/R by enhancing autophagy via AMPK-mTOR signaling pathway.

Indexed as

DeoxyadenosinesMyocardial Reperfusion InjuryAMP-Activated Protein KinasesAnimalsApoptosisAutophagyCells, CulturedInfarctionMiceMyocytes, CardiacRatsTOR Serine-Threonine KinasesAMP-Activated Protein KinasescordycepinDeoxyadenosinesTOR Serine-Threonine KinasesAMPK/mTORAutophagyCordycepinIschemia reperfusion injury

Identifiers

PMID35230668
OpenAlexW4214692716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.